Bookmark and Share
BioAssay Select:

Show Data: Show Clear
Result Display Option
Group Results By:
Compound Duplicate Test Option:
Show Data Table: Concise Complete.

   AID: 624080
Late stage assay provider results from the probe development efforts to identify inhibitors of VIM-2 metallo-beta-lactamase (nonselective): Growth inhibition of clinically relevant VIM-2 transformed P. aeruginosa (PA641) in the presence of imipenem (synergy)
Data Source: The Scripps Research Institute Molecular Screening Center (VIM-2-PAERUGINOSA_INH_ABS_384_SYNERGY MDCSRUN PA641)
BioAssay Version: 1.2

Select BioAssay Results:
  Summary Results
Activity Outcome:
MIC [4 fold reduction]*Value Range
50 :: 100
From To
BioAssay Result Version
BioAssay Data Source
* Activity Concentration.

  Other Experimental Results

Contributed Cross References
BioAssay Data Source Links

  Additional Results Filter

Other Filters:

   Substance Filter

   Compound Filter

   Select Other BioAssays

Show Data: Show Clear